Royalty Pharma (RPRX) Acquisitions (2025)
Royalty Pharma's (RPRX) quarterly Acquisitions came in at $226000.0 in Q3 2025.
Royalty Pharma (RPRX) Acquisitions (2025) Analysis & Trends
Royalty Pharma has disclosed Acquisitions across 1 years of filings, most recently posting $226000.0 for Q3 2025.
- Acquisitions for Q3 2025 came in at $226000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was $226000.0 (changed N/A YoY), and the FY2025 annual result was $74.4 million, changed N/A from the prior year.
- Acquisitions came in at $226000.0 for Q3 2025 at Royalty Pharma.
- In the past five years, Acquisitions ranged from a high of $226000.0 in Q3 2025 to a low of $226000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Acquisitions (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Royalty Pharma | 23.13 Bn | 25.57 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 226,000.00 |